Skip to main content
Medical information Clinical review pending

Genetic Testing

Microarray 60K Peripheral Blood, Cord Blood, Fetal Blood Karyotyping

The Microarray 60K test analyzes blood samples (peripheral, cord, or fetal) to detect chromosomal abnormalities, providing crucial genetic insights for expectant parents and individuals with genetic concerns.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Peripheral blood (EDTA tube), Cord blood, or Fetal blood sample. Confirm specific volume requirements with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for peripheral blood collection. For cord blood or fetal blood, collection procedures are specific and should be coordinated with the healthcare provider.
Test priceKSh 45,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Microarray 60K Peripheral Blood, Cord Blood, Fetal Blood Karyotyping test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Prenatal screening for chromosomal abnormalities.
  • ✓Diagnosis of suspected genetic syndromes.
  • ✓Investigation of developmental delays or intellectual disability.
  • ✓Evaluation of congenital anomalies.
  • ✓Assessment of unexplained infertility or recurrent pregnancy loss.
  • ✓Family history of chromosomal disorders.
02

In plain language

What this test helps you understand

Detects chromosomal abnormalities (copy number variations, aneuploidies) in peripheral blood, cord blood, or fetal blood samples. Useful for prenatal screening, diagnosis of genetic syndromes, and investigation of developmental delays or congenital anomalies.
The Microarray 60K Peripheral Blood, Cord Blood, Fetal Blood Karyotyping test is an advanced genetic analysis used to identify chromosomal abnormalities in various blood samples. This test is important for understanding genetic conditions that may affect health and development. It uses modern technology to provide detailed information that can help guide clinical decisions.

This test examines the genetic material in blood samples, looking for chromosomal abnormalities or variations linked to genetic disorders. It provides a comprehensive overview of the chromosomes in the sample.

Individuals who might consider this test include expectant mothers, those with a family history of genetic disorders, patients with symptoms of genetic conditions, and individuals needing genetic assessment for travel abroad. A doctor’s prescription is typically required, except for surgery and pregnancy-related cases.

Benefits include early detection of genetic disorders, informed decision-making for family planning and management, peace of mind for expectant parents, and access to personalized treatment options based on genetic findings.

Results provide a detailed overview of the chromosomal composition. Your healthcare provider will help interpret the results and discuss next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for peripheral blood collection. For cord blood or fetal blood, collection procedures are specific and should be coordinated with the healthcare provider.
SamplePeripheral blood (EDTA tube), Cord blood, or Fetal blood sample. Confirm specific volume requirements with the laboratory before booking.
MethodologyChromosomal microarray analysis (CMA) using a high-density oligonucleotide array.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects copy number variations and aneuploidies but may not detect all types of genetic abnormalities, such as balanced translocations or single nucleotide variants. Results may be affected by sample quality. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Peripheral blood, cord blood, or fetal blood samples can be used for this test.
Yes, a doctor’s prescription is typically required for this test, except for cases related to surgery and pregnancy.
Turnaround time varies. Please confirm the current estimated turnaround time with the laboratory before booking.
This test detects chromosomal abnormalities, such as missing or extra pieces of chromosomes (copy number variations) and aneuploidies.
No, this test focuses on chromosomal abnormalities. It may not detect all types of genetic changes, such as single gene mutations.
Home sample collection services may be available. Please inquire with the laboratory for details and eligibility.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp